Alim Ladha, Ph.D. - MPM Capital
![Alim Ladha, Ph.D. - MPM Capital](https://mpmcapital.com/wp-content/uploads/2022/10/photo-alim.jpg)
Dr. Alim Ladha is a Principal at MPM BioImpact where he is responsible for investment identification, due diligence, business development, and company creation activities. Prior to joining MPM BioImpact, Alim completed his Ph.D. in Biological Engineering at the Massachusetts Institute of Technology (MIT) in Feng Zhang’s lab at the Broad Institute where he focused on … Read more
![](https://pbs.twimg.com/media/EiEh6-8X0AEPIXT.jpg)
Alim Ladha (@LadhaAlim) / X
![](https://pbs.twimg.com/media/EiEs7BuXsAEWa6-.jpg)
Alim Ladha (@LadhaAlim) / X
Mary Lou, CFA on LinkedIn: #biotech #venturecapital #mpmcapital
![](https://mpmcapital.com/wp-content/uploads/2022/10/photo-todd.jpg)
Team - MPM Capital
MPM Capital CEO And Leadership: Executives and Demographics - Zippia
![](https://mpmcapital.com/wp-content/uploads/2022/12/Brendan-Furey-2-scaled-e1673287090912.jpg)
Team - MPM Capital
Customer Throughput Summary Report 02 Aug 2021 0524-08-22
Devin Quinlan - Principal - MPM BioImpact
![](https://www.researchgate.net/publication/359388403/figure/fig7/AS:11431281096478717@1668161083431/figure-supplement-1D-40-mM-Tris-pH-74_Q320.jpg)
Alim LADHA, Massachusetts Institute of Technology, MA
![](https://www.researchgate.net/publication/339087911/figure/fig3/AS:860694815727616@1582217043215/Effects-of-HGPS-viECs-on-TEBV-Structure-and-Function-A-Response-to-1-mM-phenylephrine_Q320.jpg)
Alim LADHA, Massachusetts Institute of Technology, MA
Alim Ladha's Investing Profile - MPM Capital Senior Associate
![](https://mpmcapital.com/wp-content/uploads/2022/10/photo-uciane-2.jpg)
Team - MPM Capital
![](https://i0.wp.com/pharmaceuticalintelligence.com/wp-content/uploads/2021/05/2.1.1.1.png?ssl=1)
Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA